Benitec Biopharma Inc.
BNTC • NASDAQ
Benitec Biopharma Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jerel A. Banks, with a market cap of $399.1M.
CEOJerel A. Banks
Market Cap$399.1M
Biotechnology
Healthcare
Employees16.0
Websitebenitec.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Benitec Biopharma Inc.
Date
Friday, February 20, 2026 (in 1 week)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.23
Earnings History
Past 12 earnings reports for Benitec Biopharma Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q1 2026 | -$0.22Est: -$0.33 | +33.3% | - | — |  10-Q |
| Sep 22, 2025 | Q4 2025 | -$0.42Est: -$0.30 | -40.0% | - | — | 10-K |
| May 14, 2025 | Q3 2025 | -$0.24Est: -$0.36 | +33.3% | - | — | 10-Q |
| Feb 14, 2025 | Q2 2025 | -$0.33Est: -$0.58 | +43.1% | - | — | 10-Q |
| Nov 14, 2024 | Q1 2025 | -$0.48Est: -$0.43 | -11.6% | - | — | 10-Q |
| Sep 26, 2024 | Q4 2024 | -$0.60Est: -$0.43 | -39.5% | - | — | 10-K |
| May 13, 2024 | Q3 2024 | -$1.64Est: -$0.78 | -110.3% | - | — | 10-Q |
| Feb 13, 2024 | Q2 2024 | -$2.64 | — | - | — | 10-Q |
| Nov 13, 2023 | Q1 2024 | -$2.76 | — | - | — | — |
| Sep 21, 2023 | Q4 2023 | -$2.73 | — | $7.0K | — | 10-K |
| May 15, 2023 | Q3 2023 | -$2.72Est: -$3.40 | +20.0% | $54.0K | — | 10-Q |
| Feb 13, 2023 | Q2 2023 | -$3.40Est: -$1.87 | -81.8% | $14.0K | — | — |